BRIEF-Sumitomo Dainippon Pharma completes full acquisition of Cynapsus Therapeutics via unit
October 23, 2016 at 22:10 PM EDT
* Says its US-based unit completes full acquisition of 100 percent stake of shares and entire warrants in Cynapsus Therapeutics Inc, on Oct. 21 (U.S.A. Eastern Standard Time), at about $635 million
